Sort   by:  
 Page size 
UnknownEfficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Not available
S-EPMC4872317 | biostudies-literature
UnknownPhase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.
Not available
S-EPMC3494837 | biostudies-literature
UnknownOutcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.
Not available
S-EPMC5012712 | biostudies-literature
Sort   by:  
 Page size